Author:
Ilett Elizabeth,Kottke Timothy,Donnelly Oliver,Thompson Jill,Willmon Candice,Diaz Rosa,Zaidi Shane,Coffey Matt,Selby Peter,Harrington Kevin,Pandha Hardev,Melcher Alan,Vile Richard
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference50 articles.
1. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded;Cattaneo;Nat Rev Microbiol,2008
2. OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected state IIIB/C and IV melanoma;Hans Ingemar Andtbacka;J Clin Oncol,2013
3. Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses;Altomonte;Microb Biotechnol,2012
4. Thunder and lightning: immunotherapy and oncolytic viruses collide;Melcher;Mol Ther,2011
5. Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?;Stanford;Curr Opin Mol Ther,2008
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献